Vitiligo

James Mcleod is a Vitiligo patient advocate and someone who has been living with vitiligo since he was a child. In this interview, we talk about what it was like for him growing up with vitiligo, how he’s learned to cope over the years, and what he’s doing now to help others who are dealing...

The first step in any successful treatment plan is acceptance. As a patient himself, James McLeod knows this all too well. He’s lived with vitiligo since he was a kid and has been through the ups and downs. In this interview, he gives his advice to patients who just got diagnosed with vitiligo. What advice...

Treatment delays can cause complications later on for patients with vitiligo. This study analyzed demographic disparities related to increased treatment delays among those exhibiting vitiligo symptoms. Delayed treatment of vitiligo is known to decrease the chance of successful disease stabilization and repigmentation due to how much more effective therapies are during the early stages of...

This article provides a population-based study about self-reported vitiligo prevalence among adults in the United States, which is especially valuable as a way to understand the rates of undiagnosed vitiligo. The prevalence of vitiligo in the United States population, as it relates to various demographic subgroups, can be a good way of understanding public health-related...

In this interview, Dr. Kaminska sheds more light on one of the most misunderstood autoimmune diseases, which affects millions worldwide – vitiligo. In this interview, she explains how vitiligo develops, how many have vitiligo, and its symptoms. Vitiligo is an autoimmune disease that causes skin cells to gradually lose their pigment. It can affect any...

Vitiligo may be a complication of treatment for psoriasis. In one case study, a patient being treated with ixekizumab for psoriasis developed vitiligo, which may be due to the drug’s mechanism of action. Vitiligo is an acquired depigmenting skin disorder characterized by melanocyte loss and low health-related quality of life. Psoriasis, another autoimmune skin disease,...

Researchers have found that transplantation of melanocytes in conjunction with dermabrasion is effective for treating vitiligo. This new treatment technique can be considered a viable option that healthcare providers can recommend to their patients with vitiligo. Vitiligo is a chronic, inflammatory skin disease that causes depigmented patches on the skin. These patches are caused by...

Metabolic syndrome may be associated with vitiligo in different age groups. One study suggests that vitiligo may be a risk factor for metabolic dysfunction, which may warrant the need for screening in some patients. In the last few decades, links between systemic vitiligo and potential metabolic disturbances have caused some concern. Based on the criteria...

Vitiligo is a complex skin condition influenced by several factors, including diet. Complementary therapeutic approaches involving diet and/or supplementation may be beneficial for patients with vitiligo. Vitiligo is a skin pigmentation disorder that can develop over time and affects 0.5 to 2% of the world’s population. Vitiligo can be a difficult condition to treat, prompting...